190 related articles for article (PubMed ID: 22453590)
1. An open-label pilot study of naftifine 1% gel in the treatment of seborrheic dermatitis of the scalp.
Gold MH; Bridges T; Avakian EV; Plaum S; Fleischer AB; Hardas B
J Drugs Dermatol; 2012 Apr; 11(4):514-8. PubMed ID: 22453590
[TBL] [Abstract][Full Text] [Related]
2. An open-label study of naftifine hydrochloride 1% gel in the treatment of tinea versicolor.
Gold MH; Bridges T; Avakian E; Plaum S; Pappert EJ; Fleischer AB; Hardas B
Skinmed; 2011; 9(5):283-6. PubMed ID: 22165042
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris.
Parish LC; Parish JL; Routh HB; Avakian E; Olayinka B; Pappert EJ; Plaum S; Fleischer AB; Hardas B
J Drugs Dermatol; 2011 Oct; 10(10):1142-7. PubMed ID: 21968664
[TBL] [Abstract][Full Text] [Related]
5. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
[TBL] [Abstract][Full Text] [Related]
6. An open-label study of the safety and efficacy of sertaconazole nitrate in the treatment of seborrheic dermatitis.
Elewski BE; Cantrell WC
J Drugs Dermatol; 2011 Aug; 10(8):895-9. PubMed ID: 21818511
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study.
Draelos ZD; Feldman SR; Butners V; Alió Saenz AB
J Drugs Dermatol; 2013 Jan; 12(1):e1-6. PubMed ID: 23377341
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial.
Elewski B; Ling MR; Phillips TJ
J Drugs Dermatol; 2006; 5(7):646-50. PubMed ID: 16865870
[TBL] [Abstract][Full Text] [Related]
9. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography.
Dall' Oglio F; Tedeschi A; Fusto CM; Lacarrubba F; Dinotta F; Micali G
G Ital Dermatol Venereol; 2017 Oct; 152(5):436-440. PubMed ID: 28121079
[TBL] [Abstract][Full Text] [Related]
10. Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study.
Reygagne P; Poncet M; Sidou F; Soto P
Cutis; 2007 May; 79(5):397-403. PubMed ID: 17569404
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study.
Diehl C; Ferrari A
J Drugs Dermatol; 2013 Mar; 12(3):312-5. PubMed ID: 23545914
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis.
Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B
J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309
[TBL] [Abstract][Full Text] [Related]
13. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
Elewski BE; Abramovits W; Kempers S; Schlessinger J; Rosen T; Gupta AK; Abraham S; Rowell R
J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
[TBL] [Abstract][Full Text] [Related]
14. Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk.
Rallis E; Nasiopoulou A; Kouskoukis C; Koumantaki E
Drugs Exp Clin Res; 2004; 30(5-6):191-5. PubMed ID: 15700745
[TBL] [Abstract][Full Text] [Related]
15. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
Elewski B
Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
[TBL] [Abstract][Full Text] [Related]
16. Ciclopirox gel for seborrheic dermatitis of the scalp.
Aly R; Katz HI; Kempers SE; Lookingbill DP; Lowe N; Menter A; Morman M; Savin RC; Wortzman M
Int J Dermatol; 2003 Sep; 42 Suppl 1():19-22. PubMed ID: 12895183
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis.
Ratnavel RC; Squire RA; Boorman GC
J Dermatolog Treat; 2007; 18(2):88-96. PubMed ID: 17520465
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial.
Lebwohl M; Plott T
Int J Dermatol; 2004 Jul; 43 Suppl 1():17-20. PubMed ID: 15271196
[TBL] [Abstract][Full Text] [Related]
19. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
20. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
